Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1336
| Despition | Estrogen Receptor alpha Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1107 | Recombinant Human Syndecan-1 Protein (Fc Chimera 6xHis Tag) (AC1107) | 50 µg | inquiry |
| ACPP-1499 | Mouse RAPSN Protein (AC1499) | 5 µg | inquiry |
| ACPP-1135 | ACTH Blocking Peptide (AC1135) | 250 µg | inquiry |
| ACPP-1497 | Human AMIGO2 Protein (AC1497) | 2 µg | inquiry |
| ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg | inquiry |
| ACPP-1793 | Human HSPB8 Protein, His (AC1793) | 2 µg | inquiry |
| ACPP-1250 | Lin28 Blocking Peptide (AC1250) | 250 µg | inquiry |
| ACPP-1388 | Human FDX1 Protein (AC1388) | 5 µg | inquiry |
| ACPP-1389 | AHSG (AC1389) | 10 µg | inquiry |
| ACPP-1340 | PDE7A Blocking Peptide (AC1340) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.